Ready To Make Bigger Biotech Investments, Vida Raises $600m For Second Fund

 
• By Mandy Jackson

Scrip spoke with Fred Cohen, who co-founded Vida Ventures with former Kite Pharma CEO Arie Belldegrun, about the venture capital firm's investment focus after raising its second fund in two years.

Business development idea and developing industry success through creative invention as a light bulb evolving to a gear shape as a 3D illustration.
Vida's new fund will allow it to invest about $40m per company. • Source: Shutterstock

More from Financing

More from Business